Congress of Clinical Rheumatology - East 2025

• CCR East •
• 1 May, 2025 •
• •

Nanoencapsulated Sirolimus plus Pegadricase (NASP) Demonstrates a Reduction in Gout Flares: Results from the Phase 3 DISSOLVE Studies

Angelo Gaffo, Herbert Baraf, Anand Patel, Tuhina Neogi, Rehan Azeem, Wesley DeHaan, Ben Peace , Hugues Santin-Janin, Bhavisha Desai, Naomi Schlesinger

Available materials

• CCR East •
• 1 May, 2025 •
• •

Reduction in Tophi Observed in Patients with Chronic Refractory Gout Treated with NASP: Results from Phase 3 DISSOLVE Studies

Herbert Baraf, Puja Khanna, Frédéric Lioté, Rehan Azeem, Wesley DeHaan, Ben Peace , Hugues Santin-Janin, Bhavisha Desai, Alan Kivitz

Available materials

• CCR East •
• 1 May, 2025 •
• •

Practice Patterns and Adherence with Treatment Guidance in the Management of HLH/MAS Associated with sJIA or AOSD: Insights from a Quantitative Survey

Ingrid Pan, Ashley Teusink-Cross, Amod Athavale, Amal Gulaid, Bhagyashree Oak, Brittany Smith, Abiola Oladapo, Matthew Wojdyla, Lynes Torres Cartularo, Astrela Moore

• CCR East •
• 1 May, 2025 •
• •

Efficacy and Safety of Emapalumab in Patients with Macrophage Activation Syndrome in Still’s Disease: Results from a Pooled Analysis of Two Prospective Trials

Alexei A. Grom, Uwe Ullmann, Adnan Mahmood, Josefin Blomkvist, Brian D. Jamieson, Fabrizio De Benedetti

Available materials